All Comments by
- Jun Tan on EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.
- Sébastien S. Hébert on MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons.
- Peter Nelson on MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons.
- Craig Atwood on Geneva: At Springfield Meeting, Soul-Searching About Dearth of Drugs
- A. David Smith on Toronto: 6th Sense—GWAS Picks Up New AD Risk Variant
- Roberta Diaz Brinton on News Flash: NYT Story Traces Estrogen’s Effect on Aging Brain
- Chris Norris on Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.
- Paul Coleman on Differential effects of ApoE isoforms on dendritic spines in vivo: linking an Alzheimer's disease risk factor with synaptic alterations.
- Elliott Mufson on Caspase activation precedes and leads to tangles.
- Hiroshi Mori on A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.
- Cynthia Lemere on A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.
- Takaomi Saido on Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway.
- Susanne Aileen Funke on High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
- Weiming Xia on High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
- Lars Lannfelt on High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.